The revolutionary impact of immune checkpoint inhibitors (ICIs) has transformed cancer care, yielding unprecedented durable responses across a spectru
Read Full Article To Earn PointsDaily news to keep you up to date
Participate and win exciting prizes
Participate and win cash vouchers
Get updates on the latest events happening around the world
1.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
2.
New BiTE Agent for Small Cell Lung Cancer Approved by the FDA.
3.
Morning Immunotherapy Does Not Boost Lung Cancer Survival
4.
Glioblastoma cells can 'unstick' from their neighbors to become more deadly
5.
The clinical trial of ENZAMET shows promise as a treatment for prostate cancer.
1.
Recombinant ADAMTS13: Advancing Prophylaxis in Congenital TTP Management
2.
Beyond the Blood: Expanding CAR T-Cell Therapy to Solid Tumors- A New Era of Precision Oncology
3.
Bone-on-a-Chip Systems: A Revolutionary Approach to Modeling Hematological Cancers
4.
Hematologic Toxicity of CDK4/6 Inhibitors in Breast Cancer: Meta-Analysis and Safety Data
5.
Precision Oncology: Tailoring Cancer Treatment for the Individual
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
2.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
5.
Navigating the Complexities of Ph Negative ALL - Part XI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation